Top Markets
Coin of the day
StageZero Life Sciences Ltd. StageZero Life Sciences Ltd.

StageZero Life Sciences Ltd.

SZLS
Rang in aandelen #36214
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Aandeelprijs
$0.02770208
Laatst gesynchroniseerd: 2025-03-10
Marktkapitalisatie
$2.92M
Verandering (1 dag)
-0.46%
Verandering (1 jaar)
0.00%
Land
CA
Handel StageZero Life Sciences Ltd. (SZLS)

Categorie

Aandelsplitsingen voor StageZero Life Sciences Ltd. (SZLS)
Het aandeel StageZero Life Sciences Ltd. (symbool: SZLS) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 16, 2026.
Eén aandeel SZLS dat vóór Aug 16, 2026 werd gekocht, staat nu gelijk aan 0 aandelen SZLS.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US